A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors

Clinical trial NCT05946226 · UNKNOWN

Trial details

NCT number: NCT05946226
Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Digestive System Tumor

Start date: 2023-09-07
Primary completion: 2025-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.